The assets of collapsed proton beam therapy developer Advanced Oncotherapy (AVO) are set to be sold off following a failed attempt to rescue the business as a going concern. David Hudson and Ian Corfield of FRP Advisory were appointed joint administrators for the former AIM-listed business at the end of May after its proposed refinancing…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2026 All rights reserved LaingBuisson
 are being liquidated following a failed attempt to rescue the business as a going concern.){kind=link}